Maaike J. Vos

1.3k total citations
48 papers, 910 citations indexed

About

Maaike J. Vos is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Maaike J. Vos has authored 48 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 20 papers in Pulmonary and Respiratory Medicine and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Maaike J. Vos's work include Glioma Diagnosis and Treatment (35 papers), Brain Metastases and Treatment (14 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). Maaike J. Vos is often cited by papers focused on Glioma Diagnosis and Treatment (35 papers), Brain Metastases and Treatment (14 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). Maaike J. Vos collaborates with scholars based in Netherlands, United States and United Kingdom. Maaike J. Vos's co-authors include Tjeerd J. Postma, J.J. Heimans, Linda Dirven, Jaap C. Reijneveld, Martin Taphoorn, Johan A F Koekkoek, Martin Klein, W. Peter Vandertop, Ben J. Slotman and Martin Klein and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Maaike J. Vos

42 papers receiving 890 citations

Peers

Countries citing papers authored by Maaike J. Vos

Since Specialization

Citations

This map shows the geographic impact of Maaike J. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maaike J. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maaike J. Vos more than expected).

Fields of papers citing papers by Maaike J. Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maaike J. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maaike J. Vos. The network helps show where Maaike J. Vos may publish in the future.

Co-authorship network of co-authors of Maaike J. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Maaike J. Vos. A scholar is included among the top collaborators of Maaike J. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maaike J. Vos. Maaike J. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patterns of Recurrence After Postoperative Stereotactic Radiotherapy for Brain Metastases 2025 ·Cancers ·(unknown), A. Petoukhova, (unknown), (unknown), Rishi Nandoe Tewarie, Rob J.A. Nabuurs, Maaike J. Vos, Melissa Kerkhof, Thijs van der Vaart, Johan A F Koekkoek, (unknown), (unknown), Lisette M. Wiltink, (unknown), M. Kiderlen, Marike L. D. Broekman, M. Mast, Jaap Zindler	0
2	Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scale 2025 ·Quality of Life Research ·Ogechukwu A Asogwa, Johan A F Koekkoek, (unknown), Hanneke Zwinkels, Maaike J. Vos, Linda Dirven, Martin Taphoorn	0
3	Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients 2025 ·Neurology ·Pim B. van der Meer, Melissa Kerkhof, Linda Dirven, Marta Fiocco, Maaike J. Vos, Mathilde C.M. Kouwenhoven, Tjeerd J. Postma, Jacoline E. C. Bromberg, Martin J. van den Bent, Martin Taphoorn, Johan A F Koekkoek	0
4	Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy 2023 ·Neurology ·Pim B. van der Meer, Linda Dirven, Marta Fiocco, Maaike J. Vos, Mathilde C.M. Kouwenhoven, Martin J. van den Bent, Martin Taphoorn, Johan A F Koekkoek	2
5	Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study 2023 ·Journal of Neuro-Oncology ·Pim B. van der Meer, Linda Dirven, Marta Fiocco, Maaike J. Vos, Melissa Kerkhof, Mathilde C.M. Kouwenhoven, Martin J. van den Bent, Martin Taphoorn, Johan A F Koekkoek	4
6	Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study 2022 ·BMC Medical Genomics ·(unknown), Marike L. D. Broekman, Filip De Vos, Edwin Cuppen, Jacobus J. M. van der Hoeven, Myra E. van Linde, Annette Compter, Laurens V. Beerepoot, Martin J. van den Bent, Maaike J. Vos, Helle‐Brit Fiebrich, Johan A F Koekkoek, Ann Hoeben, Kuan H. Kho, C.M.L. Driessen, (unknown), Pierre A. Robe, Sybren L. N. Maas	5
7	Prediagnostic symptoms and signs of adult glioma: the patients’ view 2020 ·Journal of Neuro-Oncology ·(unknown), Linda Dirven, Johan A F Koekkoek, (unknown), (unknown), Maaike J. Vos, Martin Taphoorn	13
8	Advance care planning in glioblastoma patients: development of a disease-specific ACP program 2019 ·Supportive Care in Cancer ·(unknown), Hanneke Zwinkels, Johan A F Koekkoek, Jaap C. Reijneveld, Maaike J. Vos, Linda Dirven, H. Roeline W. Pasman, Martin Klein	28
9	Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy 2018 ·Journal of Neuro-Oncology ·Melissa Kerkhof, (unknown), Ruud Wiggenraad, Geert J. Lycklama à Nijeholt, Sebastiaan Hammer, Martin Taphoorn, Linda Dirven, Maaike J. Vos	22
10	Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial 2017 ·Neuro-Oncology ·Renske Gahrmann, Martin J. van den Bent, Bronno van der Holt, René M. Vernhout, Walter Taal, Maaike J. Vos, Jan Cees de Groot, Laurens V. Beerepoot, Jan Buter, Zwenneke Flach, Monique C.J. Hanse, Bas Jasperse, Marion Smits	37
11	Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis 2016 ·Journal of Neuro-Oncology ·(unknown), Tjeerd J. Postma, Marinus A. Blankenstein, (unknown), Maaike J. Vos, Eefje M. Sizoo, M. de Groot, Bernard M.J. Uitdehaag, Jan Buter, Martin Klein, Jaap C. Reijneveld, Jan J. Heimans	19
12	The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial 2015 ·European Journal of Cancer ·Linda Dirven, Martin J. van den Bent, Andrew Bottomley, (unknown), Bronno van der Holt, Maaike J. Vos, Annemiek Walenkamp, Laurens V. Beerepoot, Monique C.J. Hanse, Jaap C. Reijneveld, (unknown), Filip De Vos, Marion Smits, Jacoline E. C. Bromberg, Walter Taal, Martin Klein	37
13	Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide 2015 ·Journal of Neuro-Oncology ·Johan A F Koekkoek, Linda Dirven, J.J. Heimans, Tjeerd J. Postma, Maaike J. Vos, Jaap C. Reijneveld, Martin Taphoorn	26
14	Serum S-100B Protein Is A Predictor of Survival in Recurrent Glioma 2010 ·Neuro-Oncology ·(unknown), T.J. Postma, Maaike J. Vos, Bernard M.J. Uitdehaag, (unknown), Jan Buter, Jaap C. Reijneveld, J. J. Heimans	1
15	Health-related quality of life of long-term high-grade glioma survivors 2008 ·Neuro-Oncology ·Ingeborg Bosma, Jaap C. Reijneveld, Linda Douw, Maaike J. Vos, Tjeerd J. Postma, Neil K. Aaronson, Martin J. Muller, W. Peter Vandertop, Ben J. Slotman, Martin Klein, J.J. Heimans, Martin Klein	66
16	Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma 2007 ·Nuclear Medicine Communications ·Maaike J. Vos, (unknown), Otto S. Hoekstra, Tjeerd J. Postma, J.J. Heimans, Lotty Hooft	25
17	The course of neurocognitive functioning in high-grade glioma patients1 2006 ·Neuro-Oncology ·Ingeborg Bosma, Maaike J. Vos, J.J. Heimans, Martin Klein, Neil K. Aaronson, Tjeerd J. Postma, Henk M. van der Ploeg, Martín Müller, W. Peter Vandertop, Ben J. Slotman, Martin Klein	131
18	Thallium-201 SPECT: the optimal prediction of response in glioma therapy 2005 ·European Journal of Nuclear Medicine and Molecular Imaging ·Maaike J. Vos, Johannes Berkhof, Tjeerd J. Postma, Otto S. Hoekstra, Frederik Barkhof, J.J. Heimans	10
19	Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Maaike J. Vos, Bernd Turowski, Friedhelm E. Zanella, Philippe Paquis, Axel Siefert, Katalin Hidéghety, K. Haselsberger, Frank Grochulla, Tjeerd J. Postma, Andrea Wittig, Jan J. Heimans, Ben J. Slotman, W. Peter Vandertop, W. Sauerwein	37
20	Interobserver variability in the semi-quantitative assessment of 201Tl SPECT in cerebral gliomas 2004 ·Nuclear Medicine Communications ·(unknown), Maaike J. Vos, Johannes Berkhof, Tjeerd J. Postma, Arthur van Lingen, J.J. Heimans, Otto S. Hoekstra	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact